Copy Link Print Information

Cadonilimab

(Synonyms: AK104)
1 Cited Publications
Revisión del cliente

Based on 1 publication(s) in Google Scholar

Cadonilimab (AK104) is a humanized tetravalent IgG1 bispecific antibody targeting PD1/CTLA4. Cadonilimab blocks both PD-1 and CTLA-4 pathways, thereby relieving their corresponding immunosuppressive effects and reversing tumor specific T cell exhaustion. Cadonilimab significantly downregulates Fc-mediated effector functions, including antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement dependent cytotoxicity (CDC). Cadonilimab can be used for research of metastatic cervical cancer, as well as other malignancies such as gastric cancer, GEJ adenocarcinoma and non-small cell lung cancer (NSCLC).

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.87%
  • No. CAS: 2394841-59-7
  • Peso molecular:198.64 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Cadonilimab
  • Experimental Validation Results for Cadonilimab
  • Experimental Validation Results for Cadonilimab
  • Experimental Validation Results for Cadonilimab
  • Experimental Validation Results for Cadonilimab
  • Cadonilimab Chemical Structure
    Cadonilimab Chemical Structure
No. CAS: 2394841-59-7
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Cadonilimab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Cadonilimab

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    IgG1-kappa-[scFv-heavy-lambda]2

  • 1/16

    Immobilized Cadonilimab can bind Human PD-1 Protein (ECD, His Tag). The EC50 for this effect is 0.197 ng/mL.

  • 1/16

    Immobilized Cadonilimab can bind Human CTLA-4 Protein (His Tag). The EC50 for this effect is 3.07 ng/mL.

  • 1/16

    Immobilized Cadonilimab can bind Human CTLA-4 Protein (His Tag). The EC50 for this effect is 3.07 ng/mL. Flow Cytometry analysis of Raji cells labelling CTLA4 (red) with Cadonilimab (anti-CTLA4) (HY-P99117). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • 1/16

    Flow Cytometry analysis of THP-1 cells labelling PDCD1 (red) with Cadonilimab (anti-PDCD1) (HY-P99117). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Cadonilimab Chemical Structure
    1/16
  • Cadonilimab
  • Immobilized Cadonilimab can bind Human PD-1 Protein (ECD, His Tag). The EC50 for this effect is 0.197 ng/mL.
  • Immobilized Cadonilimab can bind Human CTLA-4 Protein (His Tag). The EC50 for this effect is 3.07 ng/mL.
  • Immobilized Cadonilimab can bind Human CTLA-4 Protein (His Tag). The EC50 for this effect is 3.07 ng/mL. Flow Cytometry analysis of Raji cells labelling CTLA4 (red) with Cadonilimab (anti-CTLA4) (HY-P99117). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • Flow Cytometry analysis of THP-1 cells labelling PDCD1 (red) with Cadonilimab (anti-PDCD1) (HY-P99117). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • IgG1-kappa-[scFv-heavy-lambda]2